Efficacy of Combined Anticholinergic Treatment and Behavioral Modification as a First Line Treatment for Nonneurogenic and Nonanatomical Voiding Dysfunction in Children: A Randomized Controlled Trial
Authors:
- 1 June 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 177 (6) , 2325-2329
Abstract
This randomized blinded clinical study was designed to compare the efficacy of tolterodine treatment combined with behavioral modification, behavioral modification alone and behavioral modification plus placebo in children with nonneurogenic, nonanatomical voiding dysfunction. A total of 72 children meeting inclusion criteria were randomly allocated to 1 of 3 groups. One group received tolterodine (1 mg twice daily) along with behavioral modification, 1 received behavioral modification only and 1 received placebo with behavioral modification. A dysfunctional voiding scoring system questionnaire was completed for all patients at the beginning of the study, and at 1 and 3 months of treatment. A total of 71 patients were evaluated. The groups did not differ with respect to age, gender and symptom score before study enrollment (p >0.05). Repeated calculations of symptom scores at 1 month of the treatment revealed a significant decrease in symptoms in all 3 groups, with a significant decrease in patients receiving tolterodine. In addition, at month 3 the symptom score of the tolterodine group was significantly lower compared to month 1, while scores remained steady in the behavioral modification and behavioral modification plus placebo groups. Tolterodine combined with behavioral modification for voiding dysfunction in children without neurological or anatomical abnormality can be recommended as a first line treatment before invasive evaluation.Keywords
This publication has 22 references indexed in Scilit:
- The Standardization of Terminology of Lower Urinary Tract Function in Children and Adolescents: Report from the Standardisation Committee of the International Children’s Continence SocietyJournal of Urology, 2006
- Diagnosis and management of dysfunctional voidingCurrent Opinion in Pediatrics, 2006
- Efficacy of tolterodine as a first‐line treatment for non‐neurogenic voiding dysfunction in childrenBJU International, 2005
- The role of video‐urodynamic studies in managing non‐neurogenic voiding dysfunction in childrenBJU International, 2004
- Use of the Dysfunctional Voiding Symptom Score to Predict Resolution of Vesicoureteral Reflux in Children With Voiding DysfunctionJournal of Urology, 2003
- USE OF TOLTERODINE IN CHILDREN WITH DYSFUNCTIONAL VOIDING: AN INITIAL REPORTJournal of Urology, 2001
- THE USE OF RADIOGRAPHY, URODYNAMIC STUDIES AND CYSTOSCOPY IN THE EVALUATION OF VOIDING DYSFUNCTIONJournal of Urology, 2001
- LONG-TERM EFFICACY OF SIMPLE BEHAVIORAL THERAPY FOR DAYTIME WETTING IN CHILDRENJournal of Urology, 2000
- THE RELATIONSHIP AMONG DYSFUNCTIONAL ELIMINATION SYNDROMES, PRIMARY VESICOURETERAL REFLUX AND URINARY TRACT INFECTIONS IN CHILDRENJournal of Urology, 1998
- Evaluation of the utility of video‐urodynamics in children with urinary tract infection and voiding dysfunctionBritish Journal of Urology, 1997